AURALGAN EAR DROPS

Pajjiż: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

phenazone, Quantity: 54 mg/mL; benzocaine, Quantity: 14 mg/mL

Disponibbli minn:

Haleon Australia Pty Ltd

Għamla farmaċewtika:

Ear Drops, solution

Kompożizzjoni:

Excipient Ingredients: glycerol; oxyquinoline sulfate

Rotta amministrattiva:

Otic

Unitajiet fil-pakkett:

15mL

Tip ta 'preskrizzjoni:

(S2) Pharmacy Medicine

Indikazzjonijiet terapewtiċi:

For effective relief of ear pain associated with Otitis Media.

Sommarju tal-prodott:

Visual Identification: Clear, viscous liquid; Container Type: Bottle; Container Life Time: 3 Years; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Registered

Data ta 'l-awtorizzazzjoni:

1991-07-04